Baird Medical Investment Holdings Limited shares rise 5.53% intraday after Brasseler USA's strategic partnership with Biolase MG.

Wednesday, Jul 23, 2025 3:09 pm ET1min read
BDMD--
Baird Medical Investment Holdings Limited rose 5.53% intraday. The increase in stock price is likely due to the announcement of a new strategic partnership between Brasseler USA and Biolase MG, making Brasseler the exclusive US provider of the Biolase YSGG advanced laser technology. This partnership is expected to enhance endodontic treatments, improve patient outcomes, and increase clinical efficiency, which could positively impact the company's financial performance.

Baird Medical Investment Holdings Limited shares rise 5.53% intraday after Brasseler USA's strategic partnership with Biolase MG.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet